Changes in quality of life following treatment for early prostate cancer

Urology

Volumn 53, Issue 1, 1999, Pages 161-168

  Clark, Jack A ^a,b   Rieker, Patricia ^c,d   Propert, Kathleen Joy ^e   Talcott, James A ^d,f  

^a Outcomes   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CONTROLLED STUDY; EARLY CANCER; ENTEROPATHY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL STATUS; SYMPTOMATOLOGY; URINARY TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 0032905042     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00457-9     Document Type: Article

References (37)

1. Schellhammer P., Cockett A., Boccon-Gibod L., et al. Assessment of endpoints for clinical trials for localized prostate cancer. Urology. 49:(suppl 4A):1997;27-38.
2. Altwein J., Ekman P., Barry M., et al. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology. 49:(suppl 4A):1997;66-76.
3. Landis S., Murray T., Bolden S., et al. Cancer statistics, 1998. CA Cancer J Clin. 48:1998;6-29.
4. Moinpour C., Feigl P., Metch B., et al. Quality of life end points in cancer clinical trials review and recommendations . J Natl Cancer Inst. 81:1989;485-495.
5. Aaronson N., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30 a quality of life instrument for use in international clinical trials in oncology . J Natl Cancer Inst. 85:1993;365-376.
6. Ware J., Sherbourne C. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 30:1992;473-483.
7. Beard C., Propert K., Rieker P., et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients a prospective multiinstitutional outcomes study . J Clin Oncol. 15:1997;223-229.
8. Talcott J., Rieker P., Propert K., et al. A prospective study of impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 89:1997;1117-1123.
9. Talcott J., Rieker P., Clark J., et al. Patient-reported symptoms after therapy for early prostate cancer results of a prospective cohort study . J Clin Oncol. 16:1997;275-283.
10. McHorney C., Ware J., Raczek A. The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 31:1993;247-263.
11. McHorney C., Ware J., Lu R., et al. The MOS 36-Item Short-Form Health Survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 32:1994;40-66.
12. Kravitz R., Greenfield S., Rogers W., et al. Differences in the mix of patients among medical specialties and systems of care results from the Medical Outcomes Study . J Am Med Assoc. 267:1992;1617-1623.
13. Jacobson A., DeGroot M., Samson J. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 17:1994;267-274.
14. Siu A., Ouslander J., Osterweil D., et al. Change in self-reported functioning in older persons entering a residential care facility. J Clin Epidemiol. 46:1993;1093-1101.
15. Jenkinson C., Lawrence K., McWhinnie D., et al. Sensitivity to change of health status measures in a randomized controlled trial comparison of the coop charts and the SF-36 . Qual Life Res. 4:1995;47-52.
16. Gliklich R., Hilinski J. Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res. 4:1995;27-32.
17. Lancaster T., Singer D., Sheehan M., et al. The impact of long-term warfarin therapy on quality of life. Arch Intern Med. 151:1991;1944-1949.
18. Mangione C., Phillips R., Lawrence M., et al. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol. 112:1994;1419-1425.
19. Litwin M., Hays R., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. J Am Med Assoc. 273:1995;129-135.
20. Fowler F., Barry M., Lu-Yao G., et al. Outcomes of external-beam radiation therapy for prostate cancer a study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Results areas . J Clin Oncol. 14:1996;2258-2265.
21. Fowler F., Barry M., Lu-Yao G., et al. Effect of radical prostatectomy for prostate cancer on patient quality of life results from a Medicare survey . Urology. 45:1995;1007-1015.
22. Clark J., Rieker P., Kalish L., et al. Evaluation of the SF-36 measures of health related quality of life (HRQoL) in prostate cancer. Proc Am Soc Clin Oncol. 12:1993;437.
23. Albertsen P., Aaronson N., Muller M., et al. Health-related quality of life among patients with metastatic prostate cancer. Urology. 49:1997;207-217.
24. Braslis K., Santa-Cruz C., Brickman A., et al. Quality of life 12 months after radical prostatectomy. Br J Urol. 75:1995;48-53.
25. Borghede G., Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 . Qual Life Res. 5:1996;212-222.
26. Fossa S., Wahre H., Kurth K., et al. Influence of urological morbidity on quality of life in patients with prostate cancer. Eur Urol. 31:(suppl 3):1997;3-8.
27. Moinpour C., Hayden K., Thompson I., et al. Quality of life assessment in Southwest Oncology Group trials. Oncology. 4:1990;79-89.
28. Bennett C., Greenfield S., Aronow H., et al. Patterns of treatment related to age of men with localized prostate cancer. Cancer. 67:1994;2641-2644.
29. Ware J., Kosinski J., Bayliss M., et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures summary of results from the Medical Outcomes Study . Med Care. 33:1995;AS264-AS279.
30. Kazis L., Anderson J., Meenan R. Effect sizes for interpreting changes in health status. Med Care. 27:1989;S178-S189.
31. Ware J., Snow K., Kosinski M., et al. SF-36 Health Survey: Manual and Interpretation Guide. 1993;The Health Institute, New England Medical Center, Boston.
32. Keoghane S., Lawrence K., Jenkinson C., et al. The Oxford Laser Prostate Trial sensitivity to change of three measures of outcome . Urology. 47:1996;43-47.
33. Mangione C., Goldman L., Orav J., et al. Health-related quality of life after elective surgery measurement of longitudinal changes . J Gen Intern Med. 12:1997;686-697.
34. Brenner M., Curbow B., Legro M. The proximal-distal continuum of multiple health outcome measures the case of cataract surgery . Med Care. 33:1995;AS236-AS244.
35. Kantz M., Harris W., Levitsky K., et al. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement. Med Care. 30:1992;MS240-MS252.
36. Kessler R., Mroczek D. Measuring the effects of medical interventions. Med Care. 33:1995;AS109-AS119.
37. Clark J., Wray N., Brody B., et al. Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Soc Sci Med. 45:1997;1299-1309.